Therapeutic Effects of Recombinant Growth Hormone in Improving the Growth of Thalassemia Major Patients: A Retrospective Study
Background and purpose: Beta thalassemia major is one of the most common inherited blood diseases and patients with this condition require regular blood transfusions. The resulting iron overload deposition causes endocrine gland disorders, including growth hormone (GH) abnormality. In this study, we...
Main Authors: | Ahmad Tamaddoni, Morteza Alijanpour |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2020-05-01
|
Series: | Journal of Mazandaran University of Medical Sciences |
Subjects: | |
Online Access: | http://jmums.mazums.ac.ir/article-1-15148-en.html |
Similar Items
-
Growth Failure in Thalassemia Major Patients in Samples of Iraqi Patients
by: Shaima’A Dakhel ABDULHASSAN
Published: (2024-08-01) -
Growth hormone therapy response in children with short stature
by: Amira Ahmed Gad, et al.
Published: (2023-06-01) -
Growth Hormone Deficiency
by: Colleen O'Neill, et al.
Published: (2022-11-01) -
Impact of growth hormone on scoliosis
by: Xin‐Kai Zhang, et al.
Published: (2023-12-01) -
Case report: Epilepsy during the use of recombinant human growth hormone: a report on two cases and a literature review
by: Yuan Zhou, et al.
Published: (2024-09-01)